Geode Capital Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
1,326,914
-1,035,758
-44% -$1.03M ﹤0.01% 3238
2026
Q1
$1.66M Sell
2,362,672
-155,619
-6% -$145K ﹤0.01% 3194
2025
Q4
$3.9M Sell
2,518,291
-41,341
-2% -$66K ﹤0.01% 2899
2025
Q3
$4.05M Buy
2,559,632
+79,144
+3% +$138K ﹤0.01% 2891
2025
Q2
$5.41M Sell
2,480,488
-100,517
-4% -$243K ﹤0.01% 2688
2025
Q1
$7.05M Buy
2,581,005
+102,976
+4% +$406K ﹤0.01% 2491
2024
Q4
$10.3M Buy
2,478,029
+3,397
+0.1% +$12.8K ﹤0.01% 2352
2024
Q3
$9.63M Buy
2,474,632
+47,960
+2% +$202K ﹤0.01% 2401
2024
Q2
$9.51M Buy
2,426,672
+298,358
+14% +$1.28M ﹤0.01% 2348
2024
Q1
$8.92M Buy
2,128,314
+31,817
+2% +$149K ﹤0.01% 2391
2023
Q4
$9.85M Buy
2,096,497
+123,060
+6% +$479K ﹤0.01% 2354
2023
Q3
$6.16M Buy
1,973,437
+178,785
+10% +$719K ﹤0.01% 2529
2023
Q2
$8.24M Buy
1,794,652
+115,276
+7% +$530K ﹤0.01% 2403
2023
Q1
$8.31M Buy
1,679,376
+56,315
+3% +$277K ﹤0.01% 2377
2022
Q4
$8.86M Buy
1,623,061
+48,935
+3% +$300K ﹤0.01% 2343
2022
Q3
$10.2M Buy
1,574,126
+794,469
+102% +$4.43M ﹤0.01% 2236
2022
Q2
$3.69M Sell
779,657
-96,043
-11% -$473K ﹤0.01% 2859
2022
Q1
$6.12M Buy
875,700
+71,051
+9% +$485K ﹤0.01% 2678
2021
Q4
$8.2M Buy
804,649
+660,867
+460% +$7.1M ﹤0.01% 2592
2021
Q3
$1.75M Buy
+143,782
New +$2.17M ﹤0.01% 3413

Other funds holding MXCT

Geode Capital Management's MXCT Position: Q2 2026 in Review

Geode Capital Management reduced its MaxCyte (MXCT) stake by 44% in Q2 2026, selling an estimated $1.03M and leaving 1,326,914 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3238.

Geode Capital Management first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $10.3M in Q4 2024. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Geode Capital Management held 1,326,914 shares of MaxCyte worth $1.63M as of Q2 2026.
  • Geode Capital Management sold 1,035,758 MaxCyte shares in Q2 2026, an estimated $1.03M.
  • MaxCyte made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3238 holding.
  • Geode Capital Management first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
  • Geode Capital Management's MaxCyte position peaked at $10.3M in Q4 2024.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.